Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation ...
Early results support a fully-powered trial of 18F-PSMA PET/CT for prostate cancer detection, according to the investigators. PSMA-PET/CT with the radiotracer 18F-DCFPyl (18 F-PSMA PET/CT) may improve ...
Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...
Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...
An implantable microdevice safely delivered multiple drugs directly into prostate cancer lesions, enabling assessment of tumor-specific responses. All 14 patients successfully underwent robot-assisted ...
ARE TREATED FOR THE DISEASE. IT IS A VERY EXCITING TIME TO DO CANCER RESEARCH. DR. PHILIPPE DE CARVALHO HAS A HUGE REASON TO BE EXCITED ABOUT CANCER RESEARCH, SPECIFICALLY PROSTATE CANCER RESEARCH AND ...
Hosted on MSN
Prostate cancer symptoms on the skin: Nodules, papules, and more warning signs you should not ignore
Prostate cancer is one of the most common malignancies affecting men globally, usually developing within the prostate gland. While in its early stages, the disease is often confined to the gland ...
At repeat screening, only a low proportion of MRI scans indicated suspicion of clinically significant prostate cancer. Among men receiving their second biennial prostate cancer screening in a Swedish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback